2. Report by the SC on issues raised by Outreach Forum members during the 5^th Outreach Forum meeting in Washington in February 2015

3. Report by OIE on their activities concerning VMPs since the last VICH Outreach Forum

4. Report from SC discussions on proposed new topics from VOF

• Development of guidance on stability to address climatic zones III and IV
• Efficacy studies for combination products

5. 1^st Group Discussion of individual VICH Outreach Forum member questions : Introduction

• Pharmacovigilance in Korea
• Data requirements for "old" products/generics, bioequivalence

6.  Reporting back to plenary on outcome of 1^st group discussions: Group 1, Group 2, Group 3

7.  2^nd Group Discussion of individual VICH Outreach Forum member questions :  “Application of VICH GLs and acceptance of studies conducted according to VICH GLs”:

• Waiving TABST
  

8.  Reporting back to plenary on outcome of group discussions - Questions/discussions: Group 1, Group 2

10. Specific issues
10.1 AMR : general principles of authorization of antimicrobials - risk assessment of data according to VICH GL 27: EU, Japan, USA
10.2 Aquaculture Medicines :
Regulation for aquaculture medicines: JMAFF
Experience from VOF member: ASEAN
10.3 Herbal medicines: approach for registration - Experience from members: South Africa & Low Risk Veterinary Health Products - Interim Notification Pilot Program: Canada, Japan
10.4. The Vision for the Future